Introduction
============

The incidence of infections caused by *Candida*species in critical care has substantially increased in recent years. Recently, *Candida*infections have been increasing especially in critical care patients. Invasive candidiasis has been associated with severe sepsis, septic shock and multiple organ failure. With a clinical scenario very similar to bacterial infections, this infection is a diagnostic challenge with an estimated mortality rate of 40%.

Objective
=========

To evaluate the impact of a *Candida*score on early antifungal treatment in a general critical care unit.

Methods
=======

The Candidemia incidence rate ratio from July to December 2005 was compared with the same period in 2006 after the implementation of a *Candida*score system (Software Stata 8.0). Surveillance cultures of urine, tracheal and digestive samples from each patient were obtained weekly. According to Leon and colleagues \[[@B1]\], patients with at least two positive sites and sepsis or with total parenteral nutrition or a recent surgical intervention received antifungal treatment (fluconazole or Caspofungin) -- preemptive treatment. The incidence after the *Candida*score implementation was reduced from 1.91 (2/1,049 patient-days) to 0.92 (1/1,081 patient-days) with no statistical significance (*P*= 0.3).

Conclusion
==========

In this preliminary report, the *Candida*score seems to be a helpful tool to reduce the incidence of *Candida*infections in a general critical care unit. In a large population, the use of the *Candida*score system may assist in identifying candidates for preemptive antifungal treatment among the critical care population.
